Characterization of thromboxane A2/prostaglandin endoperoxide receptors in aorta

European Journal of Pharmacology

Volumn 317, Issue 1, 1996, Pages 91-96

  Zhang, Rongan ^a   Ogletree, Martin L ^a   Moreland, Suzanne ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

8 Epi prostaglandin F(2 ); AA 2414; BM 13505; BMS 180291; Daltroban; Smooth muscle, vascular; SQ 29,548; SQ 30,741; Thromboxane; U 46619

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(2 HEPTANAMIDOACETAMIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; DALTROBAN; IFETROBAN; PROSTAGLANDIN ENDOPEROXIDE; PROSTAGLANDIN F2 ALPHA; RECEPTOR SUBTYPE; SERATRODAST; THROMBOXANE A2 RECEPTOR; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; THROMBOXANE A2; THROMBOXANE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; METABOLISM; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; GUINEA PIGS; MALE; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDIN ENDOPEROXIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; THROMBOXANE A2;

EID: 0030581705     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00697-8     Document Type: Article

References (19)

1. Ashida, Y., T. Matsumoto, H. Kuriki, M. Shiraishi, K. Kato and S. Terao, 1989. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids, Prostaglandins 38, 91.
2. Bundy, G., 1975, The synthesis of prostaglandin endoperoxide analogues, Tetrahedron Lett. 24, 1957.
3. 2 on some isolated smooth muscle preparations, Br. J. Pharmacol. 73, 773.
4. 2-isoprostane receptors on rat vascular smooth muscle cells, Am. J. Physiol. 264, C1619.
5. 2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation, J. Pharmacol. Exp. Ther. 258, 74.
6. 2 receptors in platelets and blood vessels: Evidence for different receptors, J. Pharmacol. Exp. Ther. 233, 418.
7. 2-isoprostanes) are formed in situ on phospholipids, Proc. Natl. Acad. Sci. USA 89, 10721.
8. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. USA 87, 9383.
9. 2 α receptors and is mediated by thromboxane receptors, Circulation 86 (Suppl. I), I-298.
10. Ogletree, M.L. and G.T. Allen, 1992, Interspecies differences in thromboxane receptors: Studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles, J. Pharmacol. Exp. Ther. 260, 789.
11. Ogletree, M.L., D.N. Harris, R. Greenberg, M.F. Haslanger and M. Nakane, 1985, Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist, J. Pharmacol. Exp. Ther. 234, 435.
12. 2-receptor antagonist in vitro, Pharmacologist, 28, 186.
13. 2 /prostaglandin endoperoxide receptor antagonist, J. Pharmacol. Exp. Ther. 264, 570.
14. 2 receptor, J. Biol. Chem. 269, 19256.
15. 2 on coronary vessel tone - mechanisms of action and therapeutic implications, Eur. Heart J. 14 (Suppl. 1), 34.
16. Stegmeier, K., W. Akpan, C. Brauning, J. Pill and F.H. Schmidt, 1983, Effects of BM 13.177 on platelet functions and its antithrombotic activity, Thromb. Haemostasis 50, 378.
17. 2 receptor using structurally different antagonists, Eur. J. Pharmacol. 152, 311.
18. 2 α, in the rat, J. Clin. Invest. 90, 136.
19. Tallarida, R. and L. Jacob, 1979, Dissociation constants of competitive antagonists, in: The Dose Response Relation in Pharmacology (Springer, New York, NY) p. 61.